LENSAR

LENSAR Inventory

The Inventory of LENSAR (LNSR) as of Oct 16, 2026 is 21.52 M USD. In the previous year, Inventory was 11.43 M USD — a change of 88.31% (higher).

Inventory

21.52 MUSD

YoY

88.31%

Last updated:

Inventory of LENSAR is 2025 21.52 M USD. Inventory of LENSAR was 2024 11.43 M USD. It decreases by 88.31% higher compared to the previous year.

The LENSAR Inventory history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory
Date
Inventory
Jan 1, 2018
4.06 M USD
Jan 1, 2019
8.06 M USD
Jan 1, 2020
13.47 M USD
Jan 1, 2021
6.49 M USD
Jan 1, 2022
11.74 M USD
Jan 1, 2023
15.69 M USD
Jan 1, 2024
11.43 M USD
Jan 1, 2025
21.52 M USD
The LENSAR Inventory history
YEARInventoryYoY
21.52 MUSD+88.31%
11.43 MUSD-27.16%
15.69 MUSD+33.64%
11.74 MUSD+80.95%
6.49 MUSD-51.84%
13.47 MUSD+67.08%
8.06 MUSD+98.52%
4.06 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

LENSAR Stock analysis

What does LENSAR do? LENSAR Inc is a healthcare company based in Orlando, Florida, specializing in femtosecond laser technology for refractive cataract surgery. The company went public on September 21, 2020, and currently employs 150 full-time employees. LENSAR develops and markets femtosecond laser systems designed to treat cataracts and manage pre-existing or surgically induced corneal astigmatism. Its primary products include the LENSAR Laser System, which features Streamline IV and IntelliAxis technologies, along with associated consumable components such as a disposable patient interface device kit. The company also offers the ALLY Adaptive Cataract Treatment System, a compact device integrating femtosecond laser capabilities with enhanced laser features for single-room cataract procedures. LENSAR's technology aims to assist surgeons in achieving optimal visual outcomes during cataract surgery. The company operates within the healthcare sector, focusing on innovative solutions for ophthalmic procedures. Its headquarters in Orlando serves as the central hub for research, development, and business operations. LENSAR's website, lensar.com, provides further details about its products and services. The firm's product portfolio emphasizes precision and efficiency in surgical treatments, targeting healthcare providers seeking advanced tools for cataract management. As a publicly traded entity under the ticker LNSR, LENSAR continues to advance its technological offerings in the medical device industry. LENSAR is one of the most popular companies on Eulerpool.

Frequently Asked Questions about LENSAR stock

Inventory of LENSAR is 21.52 M USD in 2025.

Inventory of LENSAR changed from 11.43 M USD to 21.52 M USD, representing a 88.31% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Inventory LENSAR since 2006 – with annual values, charts, and detailed analysis.

Inventory includes raw materials, work-in-progress, and finished goods. Efficient inventory management is crucial for profitability.

Inventory's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Inventory's LENSAR historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — LENSAR

All Key Metrics — LENSAR